Top

Familial Cancer

Published in:

01-10-2001 | Summary List

Abstracts presented at the Cancer Genetics Group Meeting,13–14 May 2002, Manchester, UK

Published in: Familial Cancer | Issue 3-4/2001

Title: Abstracts presented at the Cancer Genetics Group Meeting,13–14 May 2002, Manchester, UK
Publication date: 01-10-2001
Publisher: Kluwer Academic Publishers
Published in: Familial Cancer / Issue 3-4/2001
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1023/A:1021151426205

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3-4/2001

Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians

Abstracts presented at the XVth Symposium of the NetherlandsFoundation for the Detection of Hereditary Tumours,1 February 2002, Utrecht, The Netherlands

Contents of Volume 1

Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors

Jan Peutz, Harold Jeghers and a remarkable combination of polyposis and pigmentation of the skin and mucous membranes

Instructions-for-authors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer